Previous 10 | Next 10 |
home / stock / ctabf / ctabf news
Canntab Receives Medical Sales Licence from Health Canada Canada NewsWire TORONTO , Nov. 11, 2021 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab" ), the leading innovator in cannabinoid and...
Canntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc. PR Newswire TORONTO , Oct. 18, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the " Company " or " Canntab "), ...
Canntab Announces the Early Exercise of $1,259,250 Warrants Canada NewsWire TORONTO , June 3, 2021 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blen...
Over the past five years, awareness about the medicinal properties of CBD has been growing. Although Australia’s cannabis industry is still young, CBD hasn’t escaped market watchers’ attention. CBD is a cannabidiol, meaning it is a compound found in the actual...
Canntab Mourns the Loss of Co-Founder Canada NewsWire TORONTO , May 25, 2021 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the " Company " or " Canntab "), a leading innovator in cannabinoid and terpene blends in h...
Canntab Receives Export License Approval from Health Canada PR Newswire TORONTO , March 30, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terp...
Canntab Granted 3rd Patent and Receives $400K Purchase Order in Australia PR Newswire 3 rd Patent Grant with Australia following the United States and Canada Initial Australian Purchase Order of $406,200 from our Australian partner Cann Gl...
Toronto, Ontario--(Newsfile Corp. - March 3, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE:TBF1) (the " Company " or " Canntab "), the leading innovator in cannabinoid and terpene blends in hard pill form for medical and therapeutic applications, is pleased to announce t...
Mexico with 121 million citizens will likely legalize cannabis by April of this year opening the door to the largest population for potential customers; This will be a game-changing tipping point for legalization of cannabis around the world and especially throughout Latin America; ...
Toronto, Ontario--(Newsfile Corp. - February 17, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the " Company " or " Canntab "), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announced today that it has engag...
News, Short Squeeze, Breakout and More Instantly...
Canntab Therapeutics Ltd Company Name:
CTABF Stock Symbol:
OTCMKTS Market:
Canntab Therapeutics Ltd Website:
Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the " Corporation ") announces that the Ontario Securities Commission (the " OSC ") has rejected the Corporation's application for a management cease trade order (the ...
TORONTO, ON / ACCESSWIRE / November 22, 2022 / Canntab Therapeutics Limited (CSE:PILL)(OTCQB:CTABF)(FRA:TBF1) (the " Company " or " Canntab ") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is providing an update on several matters impac...
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET Canada NewsWire TORONTO , Aug. 22, 2022 /CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the " Company " or " Canntab ") a leading innovator in cannabi...